Logotype for Integra LifeSciences Holdings Corporation

Integra LifeSciences (IART) investor relations material

Integra LifeSciences Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Integra LifeSciences Holdings Corporation
Q3 2025 earnings summary30 Oct, 2025

Executive summary

  • Q3 2025 revenue reached $402.1 million, up 5.6% reported and 5% organic year-over-year, but below guidance due to supply interruptions and private label headwinds.

  • Adjusted EPS was $0.54, up 31.7% year-over-year and above guidance, while GAAP net loss was $5.4 million, reflecting ongoing quality and operational issues.

  • PriMatrix and Durepair were relaunched ahead of schedule via dual sourcing, and the Braintree facility is on track to resume production in June 2026.

  • Margin expansion initiatives target $25–$30 million in cost reductions in 2026, with portfolio prioritization guiding capital allocation toward higher growth categories.

  • Net loss for the nine months ended September 30, 2025, was $514.8 million, mainly due to a $511.4 million goodwill impairment in Q2 2025.

Financial highlights

  • Q3 2025 revenue: $402.1 million, up 5.6% reported and 5% organic year-over-year.

  • Adjusted EPS: $0.54, up 32% from Q3 2024; adjusted EBITDA margin: 19.5%, up 330 basis points.

  • GAAP gross margin: 51.5% (down from 52.6%); adjusted gross margin: 62.9% (down 10bps year-over-year).

  • Operating cash flow: $40.9 million; free cash flow: $25.8 million; adjusted free cash flow conversion: 61.9%.

  • GAAP net loss: $5.4 million; adjusted net income: $41.6 million.

Outlook and guidance

  • Q4 2025 revenue guidance: $420–$440 million (reported decline of 5% to 0.6%, organic decline of 6% to 1.4%).

  • Full year 2025 revenue guidance: $1.62–$1.64 billion (reported growth of 0.6%–1.8%, organic decline of 1.6%–0.4%).

  • Full year 2025 adjusted EPS guidance: $2.19–$2.24; Q4 2025 adjusted EPS guidance: $0.79–$0.84.

  • Gross margin expected to decline by 260 basis points for the year, mainly due to remediation, compliance investments, and tariffs.

  • Modest revenue growth anticipated in 2026, with continued focus on operational execution and cost management.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Integra LifeSciences earnings date

Logotype for Integra LifeSciences Holdings Corporation
Q4 202520 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Integra LifeSciences earnings date

Logotype for Integra LifeSciences Holdings Corporation
Q4 202520 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Integra LifeSciences Holdings Corporation develops and markets medical devices and surgical instruments for neurosurgery, orthopedics, and reconstructive surgery. The company provides implants, tissue technologies, and surgical tools used in hospitals and clinics worldwide. The company is headquartered in Princeton, New Jersey, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage